San Donato Hospital
Metastases in the liver treatment cost in Italy primarily depends on the complexity of the intervention, with a histopathology revision ranging from $200 to $400 and surgical liver resection running from $30,000 to $50,000. Total expenses are influenced by the choice between minimally invasive ablation or systemic therapies and the healthcare facility's tier. Patients can save approximately 40-60% compared to the US. Top cities for these oncological procedures include Milan, Rome, and Olbia.
Typical Metastases In The Liver Treatment Costs in Italy
Bookimed Expert Insight: Patients seeking a balance between clinical research and active treatment should consider IRCCS-accredited facilities like San Donato Hospital. Such centers are best for complex cases because they combine high surgical volumes, with over 8,400 operations annually, and academic research. This multidisciplinary environment is particularly valuable for patients requiring integrated care plans that involve both surgical resection and advanced oncology consultations.
| Italy | Turkey | Austria | |
| Removal of liver cancer | from $40,000 | from $10,800 | from $40,000 |
| Radiofrequency ablation of the liver | from $10,000 | from $3,500 | from $12,000 |
| Liver resection | from $30,000 | from $11,700 | from $35,000 |
| Chemoembolization of the liver | from $9,000 | from $7,500 | from $16,000 |
| Chemotherapy for liver cancer | from $4,500 | from $1,800 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Metastases in the liver treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Metastases in the liver treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Metastases in the liver treatment journey.
Whether liver metastases are removable depends on the volume of healthy tissue remaining after surgery. Italian specialized centers define operability by the future liver remnant rather than tumor number. If surgeons can leave 25% to 30% functional tissue, the procedure is generally possible.
Bookimed Expert Insight: Italian research hospitals like San Donato Hospital integrate clinical care with IRCCS-accredited research activity. This dual focus often provides access to advanced multidisciplinary protocols that rethink standard inoperability. For instance, San Donato manages over 300,000 patients annually through 18 specialized departments. This high volume allows their tumor boards to apply complex techniques like two-stage resections that general hospitals might not offer.
Patient Consensus: Patients emphasize that an inoperable label is often a moving target rather than a final verdict. Many report that seeking a second opinion at a high-volume center transformed their treatment plan from palliative care to potential surgery.
Italy hosts internationally recognized institutions for metastatic liver disease. These include Ospedale San Raffaele, Fondazione Policlinico Gemelli, and Istituto Nazionale Tumori. These centers hold IRCCS accreditation for excellence in research and clinical care. They utilize advanced therapies like laparoscopic liver surgery and radioembolization.
Bookimed Expert Insight: While Milan-based centers like San Raffaele garner significant global attention, the San Donato Hospital in the same city manages over 300,000 patients annually. High patient volumes often indicate robust clinical infrastructure. Patients seeking liver metastasis treatment should prioritize these high-volume IRCCS-accredited hubs. These facilities integrate surgical oncology with interventional radiology for better outcomes.
Patient Consensus: Patients note that major university hospitals in Milan and Rome often re-evaluate surgical resectability more aggressively. They suggest bringing all pathology slides to ensure a comprehensive second opinion from a multidisciplinary team.
Italy hosts globally recognized pioneers in hepatobiliary surgery and liver transplantation. Prof. Guido Torzilli is a pioneer of liver-sparing techniques. Prof. Luca Aldrighetti specializes in laparoscopic liver resections. These experts operate within Scientific Institutes for Research and Healthcare (IRCCS), ensuring high standards for oncology patients.
Bookimed Expert Insight: Milan serves as Italy's primary cluster for complex hepatobiliary care. Centers like San Donato Hospital handle 300,000 patients annually with IRCCS accreditation. This volume allows specialized teams to manage cases often labeled as inoperable elsewhere. Choosing a Milan-based IRCCS facility provides access to these high-volume surgical expertise and multidisciplinary tumor boards.
Patient Consensus: Patients value facilities where liver surgeons and medical oncologists work in one team. Many suggest bringing all imaging on disks to initial consultations to speed up treatment planning.
Italy offers advanced non-surgical local treatments for liver metastases like radiofrequency ablation (RFA) and transarterial chemoembolization (TACE). These interventional radiology techniques target tumors directly without requiring major surgery. They are ideal for patients with medical frailty or difficult tumor locations.
Bookimed Expert Insight: Italian IRCCS-accredited hospitals like San Donato combine research with clinical care for complex cases. Data shows these academic centers often handle 300,000+ patients yearly. This high volume allows multidisciplinary teams to offer local-regional therapies even when general surgeons decline to operate. Choosing an IRCCS facility ensures access to the latest national protocols for awake procedures.
Patient Consensus: Patients note that seeking a multidisciplinary liver tumor board opinion is vital. These teams often identify liver-directed treatments that single-specialty doctors might overlook as the middle ground between surgery and chemotherapy.
Advanced clinical trials and immunotherapies are highly accessible in Italy through specialized research hospitals. Leading centers utilize immune checkpoint inhibitors and dual-agent combinations. Groundbreaking research also focuses on next-generation CAR-T cell protocols. These treatments target specific proteins to eliminate metastatic liver cells while protecting healthy tissue.
Bookimed Expert Insight: Italian oncology excellence is concentrated in IRCCS-designated hospitals like San Donato Hospital in Milan. Data shows these academic centers offer unique access to trials involving gene therapy platforms. These studies test in-vivo modifications of liver immune cells to fight metastases. Patients should prioritize these research hubs to access molecular profiling beyond standard chemotherapy protocols.
Patient Consensus: Patients emphasize that eligibility for immunotherapy depend on the primary cancer type and biomarker status. Reviews for San Raffaele Hospital highlight that these organized facilities provide a calm, highly professional environment for complex treatments.